Following the announcement of the Medicines Agency Commission (ANSM) which, at the beginning of November, issued a favorable opinion on the use of Truvada as a preventive treatment against AIDS for people who are not infected but at “high risk”, the Minister of Health Marisol Touraine declared, before the National Assembly , authorize this drug in France.
A measure that will satisfy the National Agency for AIDS Research (ANRS). This association fighting against AIDS had asked in September 2015, the Minister of Health Marisol Touraine to accelerate the process of reviewing the request for RTU (Temporary Recommendation for Use). “Access to Truvada must be guaranteed for all those who urgently need it explained Bruno Spire, doctor, former president of Aides.
The antiretroviral drug Truvada, from the American laboratory Gilead is effective in reducing the risk of infection with HIV HIV-negative people. This drug has been tested by two clinical trials, the British study Proud and the French Ipergay. The results of these two studies confirm that it would be effective in reducing the risk of HIV infection in HIV-negative people. It should be taken before risky sex.
AIDS in France
An essential health announcement, to fight this disease, because if today antiretrovirals are effective in reducing the risk of HIV infection for HIV-negative people, each year, more than 6,000 new HIV infections are discovered in France. People are mostly infected sexually. The National Institute for Health Surveillance (INVS) estimates that 30,000 to 40,000 people are unaware that they are HIV positive. According to the World Health Organization, with more than 34 million deaths to date, AIDS continues to be a major public health problem. At the end of 2014, there were approximately 36.9 million people living with HIV.
Read also:
Video: A viral campaign to remember AIDS
HIV: how does it work in the body?
HIV: antiretrovirals would protect children during breastfeeding
